Page last updated: 2024-11-03

propofol and Graft vs Host Disease

propofol has been researched along with Graft vs Host Disease in 1 studies

Propofol: An intravenous anesthetic agent which has the advantage of a very rapid onset after infusion or bolus injection plus a very short recovery period of a couple of minutes. (From Smith and Reynard, Textbook of Pharmacology, 1992, 1st ed, p206). Propofol has been used as ANTICONVULSANTS and ANTIEMETICS.
propofol : A phenol resulting from the formal substitution of the hydrogen at the 2 position of 1,3-diisopropylbenzene by a hydroxy group.

Graft vs Host Disease: The clinical entity characterized by anorexia, diarrhea, loss of hair, leukopenia, thrombocytopenia, growth retardation, and eventual death brought about by the GRAFT VS HOST REACTION.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Amer, J1
Weiss, L1
Reich, S1
Shapira, MY1
Slavin, S1
Fibach, E1

Other Studies

1 other study available for propofol and Graft vs Host Disease

ArticleYear
The oxidative status of blood cells in a murine model of graft-versus-host disease.
    Annals of hematology, 2007, Volume: 86, Issue:10

    Topics: Acetylcysteine; Animals; Blood Cells; Cells, Cultured; Disease Models, Animal; Female; Flow Cytometr

2007